AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Clinical trial NCT01281254 · TERMINATED

Trial details

NCT number: NCT01281254
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Primary Peritoneal Cancer

Start date: 2011-04-18
Primary completion: 2014-08-29
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.